EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Embecta's Enterprise Value is $2,157 Mil.
Embecta's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was $159 Mil. Therefore, Embecta's EV-to-EBIT for today is 13.53.
The historical rank and industry rank for Embecta's EV-to-EBIT or its related term are showing as below:
EMBC'
s EV-to-EBIT Range Over the Past 10 Years
Min: 5.04 Med: 10.99 Max: 14.71
Current: 13.53
During the past 5 years, the highest EV-to-EBIT of Embecta was 14.71. The lowest was 5.04. And the median was 10.99.
EMBC's EV-to-EBIT is ranked better than 69.45% of 455
companies
in the Medical Devices & Instruments industry
Industry Median: 20.82
vs EMBC: 13.53
The historical data trend for Embecta's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Embecta's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Embecta's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Embecta's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Embecta's EV-to-EBIT falls into.
Embecta's current Enterprise Value is $2,157 Mil.
Embecta's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $159 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Embecta (NAS:EMBC) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Embecta's Enterprise Value for the quarter that ended in Mar. 2024 was $2,101 Mil.
Embecta's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $159 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Embecta EV-to-EBIT Related Terms
Thank you for viewing the detailed overview of Embecta's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.
Embecta Corp is a medical technology company. The company develops innovative technology, services, and solutions that help advance both clinical therapy for patients and clinical processes for healthcare providers. Its products include BD Pyxis, PureWick, Phasix among others.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
EMBC has been successfully added to your 